On the surface, problems with weight may seem simple – the body stores excess energy from food as fat. But the reality is that obesity is a complex chronic disease which can be caused by many interlinked factors.
Survey emphasises a balanced and diverse diet to deal with the burgeoning obesity problem. It also recognises mental health as a principal factor in individual & national development.
Tirzepatide is a type 2 diabetes and obesity drug sold by US firm Eli Lilly under the brand names Mounjaro and Zepbound. It may take around 6 months for it to be launched in India.
Study, conducted by NCD Risk Factor Collaboration & WHO, shows that nearly 880 million adults globally living with obesity in 2022 — 4.5 times higher than the number recorded in 1990.
Study by Australian & Canadian scientists, published in Kidney International, finds that drug may be effective at reducing inflammation — lowering risk of heart & kidney disease.
In clinical trials, tirzepatide by Eli Lilly has shown to reduce body weight by up to 22.5 percent, on average, after about 72 weeks, according to the company.
RSS chief Mohan Bhagwat has backtracked on his retirement rules. The ‘75-year rule’ was applied selectively to sideline some leaders, but it doesn’t apply to the top brass.
A public meeting, where the women voiced their protest, took place this month in Delhi, grounded on the findings of an AIDWA survey, covering 9,000 women borrowers.
Joint Doctrine for Special Forces Operations, released Wednesday, also outlines plans for the future expansion of AFSOD and the creation of Joint Service Training Institutes.
Putin sees this as a victory. Europeans have decided to deal with Trump on his terms for the sake of the larger Western alliance. We look at the lessons for us in India.
COMMENTS